Candace L Clawson, MD - Medicare Family Medicine in Anchorage, AK

Candace L Clawson, MD is a medicare enrolled "Family Medicine" physician in Anchorage, Alaska. Her current practice location is 4315 Diplomacy Dr, Anchorage, Alaska. You can reach out to her office (for appointments etc.) via phone at (907) 729-1624.

Candace L Clawson is licensed to practice in Alaska (license number 4038) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1003863671.

Contact Information

Candace L Clawson, MD
4315 Diplomacy Dr,
Anchorage, AK 99508-5926
(907) 729-1624
(907) 729-1634



Physician's Profile

Full NameCandace L Clawson
GenderFemale
SpecialityFamily Medicine
Location4315 Diplomacy Dr, Anchorage, Alaska
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1003863671
  • Provider Enumeration Date: 05/28/2006
  • Last Update Date: 10/24/2008
  Medicare PECOS Information:
  • PECOS PAC ID: 5890774533
  • Enrollment ID: I20040716000348

Medical Identifiers

Medical identifiers for Candace L Clawson such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003863671NPI-NPPES
MD0675MedicaidAK

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine 4038 (Alaska)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Candace L Clawson allows following entities to bill medicare on her behalf.
Entity NameSoutheast Alaska Regional Health Consortium
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1376758037
PECOS PAC ID: 1456265362
Enrollment ID: O20031114000631

News Archive

Advances in back care and treatment options for slipped disc, spine surgery and vertebral fractures

Approximately 21 million visits were made to physicians' offices due to back problems in 2006. While countless adults experience back pain and stiffness, many suffer from serious spine and back conditions -including injury, herniated discs and the deterioration of the vertebrae. Three new studies presented at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) detail advances in back care and treatment options for specific back and spine conditions.

Natus Medical reports increased revenue for 2009 fourth quarter

For the fourth quarter ended December 31, 2009, Natus reported revenue of $51.6 million, compared to $43.4 million reported in the comparable quarter of the previous year. Net income was $4.3 million, or $0.15 per diluted share, for the fourth quarter of 2009, compared with net income of $6.3 million, or $0.22 per diluted share, for the fourth quarter of 2008.

Updated guidelines for breast cancer increase number of patients who test HER2-positive

Changes to HER2 testing guidelines for breast cancer in 2013 significantly increased the number of patients who test HER2-positive, according to a new study by Mayo Clinic researchers published in the Journal of Clinical Oncology.

AIT, BioVendor and SCIENION partner to develop in-vitro diagnostic test for colon cancer

The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three companies will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers.

Phadia's four new EliA autoimmune antibody assays receive FDA clearance

Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.

Read more Medical News

› Verified 5 days ago

Entity NameAlaska Native Tribal Health Consortium
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1437189339
PECOS PAC ID: 6709780265
Enrollment ID: O20031125000772

News Archive

Advances in back care and treatment options for slipped disc, spine surgery and vertebral fractures

Approximately 21 million visits were made to physicians' offices due to back problems in 2006. While countless adults experience back pain and stiffness, many suffer from serious spine and back conditions -including injury, herniated discs and the deterioration of the vertebrae. Three new studies presented at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) detail advances in back care and treatment options for specific back and spine conditions.

Natus Medical reports increased revenue for 2009 fourth quarter

For the fourth quarter ended December 31, 2009, Natus reported revenue of $51.6 million, compared to $43.4 million reported in the comparable quarter of the previous year. Net income was $4.3 million, or $0.15 per diluted share, for the fourth quarter of 2009, compared with net income of $6.3 million, or $0.22 per diluted share, for the fourth quarter of 2008.

Updated guidelines for breast cancer increase number of patients who test HER2-positive

Changes to HER2 testing guidelines for breast cancer in 2013 significantly increased the number of patients who test HER2-positive, according to a new study by Mayo Clinic researchers published in the Journal of Clinical Oncology.

AIT, BioVendor and SCIENION partner to develop in-vitro diagnostic test for colon cancer

The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three companies will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers.

Phadia's four new EliA autoimmune antibody assays receive FDA clearance

Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.

Read more Medical News

› Verified 5 days ago

Entity NameTanana Chiefs Conference
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1821201278
PECOS PAC ID: 9537050109
Enrollment ID: O20050111000954

News Archive

Advances in back care and treatment options for slipped disc, spine surgery and vertebral fractures

Approximately 21 million visits were made to physicians' offices due to back problems in 2006. While countless adults experience back pain and stiffness, many suffer from serious spine and back conditions -including injury, herniated discs and the deterioration of the vertebrae. Three new studies presented at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) detail advances in back care and treatment options for specific back and spine conditions.

Natus Medical reports increased revenue for 2009 fourth quarter

For the fourth quarter ended December 31, 2009, Natus reported revenue of $51.6 million, compared to $43.4 million reported in the comparable quarter of the previous year. Net income was $4.3 million, or $0.15 per diluted share, for the fourth quarter of 2009, compared with net income of $6.3 million, or $0.22 per diluted share, for the fourth quarter of 2008.

Updated guidelines for breast cancer increase number of patients who test HER2-positive

Changes to HER2 testing guidelines for breast cancer in 2013 significantly increased the number of patients who test HER2-positive, according to a new study by Mayo Clinic researchers published in the Journal of Clinical Oncology.

AIT, BioVendor and SCIENION partner to develop in-vitro diagnostic test for colon cancer

The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three companies will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers.

Phadia's four new EliA autoimmune antibody assays receive FDA clearance

Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Candace L Clawson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Candace L Clawson, MD
4315 Diplomacy Dr,
Anchorage, AK 99508-5926

Ph: (907) 729-1624
Candace L Clawson, MD
4315 Diplomacy Dr,
Anchorage, AK 99508-5926

Ph: (907) 729-1624

News Archive

Advances in back care and treatment options for slipped disc, spine surgery and vertebral fractures

Approximately 21 million visits were made to physicians' offices due to back problems in 2006. While countless adults experience back pain and stiffness, many suffer from serious spine and back conditions -including injury, herniated discs and the deterioration of the vertebrae. Three new studies presented at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) detail advances in back care and treatment options for specific back and spine conditions.

Natus Medical reports increased revenue for 2009 fourth quarter

For the fourth quarter ended December 31, 2009, Natus reported revenue of $51.6 million, compared to $43.4 million reported in the comparable quarter of the previous year. Net income was $4.3 million, or $0.15 per diluted share, for the fourth quarter of 2009, compared with net income of $6.3 million, or $0.22 per diluted share, for the fourth quarter of 2008.

Updated guidelines for breast cancer increase number of patients who test HER2-positive

Changes to HER2 testing guidelines for breast cancer in 2013 significantly increased the number of patients who test HER2-positive, according to a new study by Mayo Clinic researchers published in the Journal of Clinical Oncology.

AIT, BioVendor and SCIENION partner to develop in-vitro diagnostic test for colon cancer

The AIT Austrian Institute of Technology, BioVendor and SCIENION today announced that the three companies will partner on the development of an in-vitro diagnostic test for colon cancer. The innovative test kit shall identify cancer at an early stage based on tumor autoantibody biomarkers.

Phadia's four new EliA autoimmune antibody assays receive FDA clearance

Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.

Read more News

› Verified 5 days ago


Family Medicine Doctors in Anchorage, AK

Dr. William Murray Buttner, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1201 E 36th Ave, Anchorage, AK 99508
Phone: 907-562-9229    Fax: 907-561-4806
Robert L Mcalister, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1201 E 36th Ave, Anchorage, AK 99508
Phone: 907-562-2992    
Shane W Cummings, M D
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 1310 E Dimond Blvd, Suite 1, Anchorage, AK 99515
Phone: 907-344-2400    Fax: 907-344-2404
Jeremy D Wood, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 910 Compassion Cir, Anchorage, AK 99504
Phone: 907-212-9200    Fax: 907-212-9283
Kelton Hillard Oliver, MD
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 12302 Woodward Dr, Anchorage, AK 99516
Phone: 907-580-0002    
Ryan T. Mcwilliams, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 4320 Diplomacy Dr, Suite 1191, Anchorage, AK 99508
Phone: 907-729-6321    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2022 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.